Clinical Trial

A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma

Name: A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma — clinical trial record (NCT06656091)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the overall survival of simmitinib versus investigator's choice of chemotherapy for Participants with advanced or metastatic oesophageal squamous cell carcinoma who have disease progression after first-line standard therapy.

Trial Details

NCT Number	NCT06656091
Lead Sponsor	Shanghai Runshi Pharmaceutical Technology Co., Ltd
Conditions	Advanced Oesophageal Squamous Cell Carcinoma
Enrollment	450 participants
Start Date	2024-10-31
Primary Completion	2027-01-30 (estimated)
Study Completion	2027-01-30 (estimated)
Updated on ClinicalTrials.gov	2024-10-24